Access all 5,000+ company profiles through the Benchmarking Pro Membership. Unlock interactive competitor comparison tools that show you how Laboratory Corporation Of America Holdings stacks up to the competition and put relevant competitor and industry information at your fingertips.
Laboratory is a public company headquartered in North Carolina with an estimated 67,000 employees. In the US, the company has a notable market share in at least three industries: Diagnostic & Medical Laboratories, Toxicology Laboratories, Contract Research Organizations and Contract Research Organizations. Their largest market share is in the Toxicology Laboratories industry, where they account for an estimated 12.9% of total industry revenue.
Of the 6 core revenue-generating products and services in the Toxicology Laboratories industry, Laboratory Corporation Of America Holdings offers:
Of the 4 core revenue-generating products and services in the Diagnostic & Medical Laboratories industry, Laboratory Corporation Of America Holdings offers:
Of the 4 core revenue-generating products and services in the Contract Research Organizations industry, Laboratory Corporation Of America Holdings offers:
Strengths and weaknesses take into account internal factors, and are based on Laboratory Corporation Of America Holdings's performance in comparison to its competitors. Opportunities and Threats focus on external influences, and are based on trends and demand in the Toxicology Laboratories , Diagnostic & Medical Laboratories , Contract Research Organizations industries
Gain strategic insight and analysis on 700+ in the United States industries
(& thousands of global industries)
BALANCE DATE | 12/31/2018 | 12/31/2019 | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2023 |
---|---|---|---|---|---|---|
Revenue | 11,333.4 | 11,554.8 | 13,978.5 | 13,136.1 | 11,863.9 | 12,161.6 |
Cost of Revenue | ||||||
Cost of Revenue, Non-Cash | ||||||
Gross Profit | ||||||
00000 |
BALANCE DATE | 12/31/2018 | 12/31/2019 | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2023 |
---|---|---|---|---|---|---|
Cash and Equivalents | 426.8 | 337.5 | 1,320.8 | 1,472.7 | 320.6 | 536.8 |
Short-Term Investments | ||||||
Derivative Assets, Current | ||||||
Restricted Cash and Investments | ||||||
00000 |
BALANCE DATE | 12/31/2018 | 12/31/2019 | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2023 |
---|---|---|---|---|---|---|
Net Income | 883.9 | 824.9 | 1,557.0 | 2,379.5 | 1,280.6 | 419.2 |
Income (Loss) From Discontinued Operations | ||||||
Depreciation, Depletion and Amortization | ||||||
Amortization of Financing Costs and Discounts | ||||||
00000 |
IBISWorld provides profiles on thousands of leading companies around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends across all sectors of the economy. This company profile, along with the corresponding competitor and industry data provided, includes thoroughly researched, reliable and current information that will help you to make faster, better business decisions.